Lv3
240 积分 2024-05-13 加入
Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study
1个月前
已完结
Comparative evaluation of radionuclide therapy using 90Y and 177Lu
5个月前
已完结
Stakeholders of Theranostics
6个月前
已关闭
Stakeholders of Theranostics
7个月前
已关闭
Is211At Really Happening?
7个月前
已完结
Theranostics and Patient-Specific Dosimetry
8个月前
已完结
Theranostics and Patient-Specific Dosimetry
8个月前
已关闭
Efficacy and Safety of Radiation Segmentectomy with 90Y Resin Microspheres for Hepatocellular Carcinoma
1年前
已完结
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
1年前
已完结
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
1年前
已完结
皖公网安备34019202002308
